Menu
Menu
We’re proud to welcome the Instituto Nacional de Cancerología (INCAN) of Mexico to the SOPHiA GENETICS community.
As Mexico’s leading national cancer institute, INCAN plays a vital role in advancing cancer prevention, research, and education across the country. By leveraging SOPHiA DDM™ Hereditary Cancer Solution, INCAN researchers can deepen their understanding of the complex landscape of hereditary cancer disorders and contribute to the development of data-driven approaches that advance precision medicine in Latin America.
At SOPHiA GENETICS, our mission is to empower institutions like INCAN with technology that transforms complex genomic data into meaningful insights. Together, we’re helping accelerate the future of oncology research, one discovery at a time.
🔗 Learn more about our Hereditary Cancer Solution: https://sophiastg.wpenginepowered.com/sophia-ddm-for-genomics/hereditary-cancers/
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
